A Quick Look at Today's Ratings for Mersana Therapeutics(MRSN.US), With a Forecast Between $6 to $8

Moomoo NewsNov 14 08:00 ET · Ratings

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

BenzingaNov 13 16:05 ET

Positive Outlook for Mersana Therapeutics Driven by Promising XMT-1660 Developments and Strategic Focus

TipRanksNov 13 15:05 ET

Mersana Therapeutics, Inc. (MRSN) Q3 2024 Earnings Call Transcript Summary

moomoo AINov 13 13:34 ET · Conference Call

Mersana Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results.

BenzingaNov 13 13:28 ET

TD Cowen Remains a Buy on Mersana Therapeutics (MRSN)

TipRanksNov 13 11:45 ET · Ratings